| Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ... The American journal of cardiology 92 (2), 152-160, 2003 | 2178 | 2003 |
| logistf: Firth’s bias reduced logistic regression G Heinze, M Ploner, D Dunkler, H Southworth R package version 1, 21, 2013 | 328 | 2013 |
| Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia AG Olsson, H Istad, O Luurila, L Ose, S Stender, J Tuomilehto, O Wiklund, ... American Heart Journal 144 (6), 1044-1051, 2002 | 233 | 2002 |
| Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized … R Paoletti, M Fahmy, G Mahla, J Mizan, H Southworth Journal of cardiovascular risk 8 (6), 383-390, 2001 | 175 | 2001 |
| Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia EA Stein, K Strutt, H Southworth, PJ Diggle, E Miller, HeFH Study Group The American journal of cardiology 92 (11), 1287-1293, 2003 | 136 | 2003 |
| Good signal detection practices: evidence from IMI PROTECT AFZ Wisniewski, A Bate, C Bousquet, A Brueckner, G Candore, K Juhlin, ... Drug safety 39, 469-490, 2016 | 132 | 2016 |
| Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome CM Ballantyne, EA Stein, R Paoletti, H Southworth, JW Blasetto The American journal of cardiology 91 (5), 25-27, 2003 | 71 | 2003 |
| gbm: Generalized Boosted Regression Models, 2010 G Ridgeway, D Edwards, B Kriegler, S Schroedl, H Southworth URL http://CRAN. R-project. org/package= gbm. R package version 2, 2015 | 64 | 2015 |
| ZD4522 is superior to atorvastatin in the treatment of patients with heterozygous familial hypercholesterolemia E Stein, KL Strutt, E Miller, H Southworth Journal of the American College of Cardiology 37 (2), 292A-292A, 2001 | 48 | 2001 |
| texmex: Statistical modelling of extreme values H Southworth, JE Heffernan, PD Metcalfe R package version 2 (4), 2020 | 43 | 2020 |
| logistf: Firth's bias reduced logistic regression. R package version 1.10 M Ploner http://CRAN. R-project. org/package= logistf, 2010 | 42 | 2010 |
| On bias in maximum likelihood estimators CCT K.V. Mardia, H.R. Southworth Journal of Statistical Planning and Influence 76, 31 - 39, 1999 | 37* | 1999 |
| Rosuvastatin (20, 40 and 80mg) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 80mg) in patients with heterozygous familial … E Stein Atherosclerosis 2, 90, 2001 | 29 | 2001 |
| Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS S Harris, JQ Tran, H Southworth, CM Spencer, BAC Cree, SS Zamvil Neurology: Neuroimmunology & Neuroinflammation 7 (5), e839, 2020 | 28 | 2020 |
| Long-term efficacy and safety of rosuvastatin: results of a 52-week comparator-controlled trial versus atorvastatin A Olsson, H Southworth, JW Wilpshaar European Heart Journal 22, 253-253, 2001 | 27 | 2001 |
| Rosuvastatin Investigators Group Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia AG Olsson, H Istad, O Luurila, L Ose, S Stender, J Tuomilehto, O Wiklund, ... Am Heart J 144 (6), 1044-1051, 2002 | 24 | 2002 |
| Extreme value modelling of laboratory safety data from clinical studies H Southworth, JE Heffernan Pharmaceutical statistics 11 (5), 361-366, 2012 | 23 | 2012 |
| Use of acoustic emission to identify novel candidate biomarkers for knee osteoarthritis (OA) DK Schlüter, L Spain, W Quan, H Southworth, N Platt, J Mercer, LK Shark, ... PLoS One 14 (10), e0223711, 2019 | 21 | 2019 |
| Predicting potential liver toxicity from phase 2 data: a case study with ximelagatran H Southworth Statistics in Medicine 33 (17), 2914-2923, 2014 | 21 | 2014 |
| Data mining and statistically guided clinical review of adverse event data in clinical trials H Southworth, M O'Connell Journal of Biopharmaceutical Statistics 19 (5), 803-817, 2009 | 21 | 2009 |
